Chem firms take part in Sweden biotech projects

16 June 2008 12:07 [Source: ICIS news]

STOCKHOLM (ICIS news)--Specialty chemicals and pharmaceutical firms are taking part in three industrial biotechnology research projects funded by the Swedish agency for innovation systems Vinnova, it said on Monday.

Vinnova will provide €5.1m ($7.8m) over five years while the costs for participating companies were not disclosed.

The first project, headed by Perstorp Specialty Chemicals, aims at developing a platform for the production of organic acids from biological resources instead of fossil raw materials.

Starch chemistry company Lyckeby, Danisco and Lund University are among the participants.

The second plans to develop process technology with immobilised biocatalysts and is headed by Cambrex Karlskoga, the Swedish arm of US active ingredients’ producer Cambrex.

GE Heathcare Biosciences, Perstorp, Protista International and Lund University are taking part.

The third project, bio-amines, will aim to replace classical chemical synthesis with biocatalysis in the pharma and chemical industries, leading to less waste and less environmental impact. AstraZeneca Process R&D will head the project.

Cambrex is participating together with the Royal Institute of Technology in Stockholm.

($1 = €0.65)

To discuss issues facing the chemical industry go to ICIS connect

By: Sverker Nyman
44 20 8652 3214

< previous article(VIDEO – ICIS news Americas Lunchtime Bulletin 29 Oct 2009)

For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.

Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.

Printer Friendly